Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
patient received adjuvant without powder; patient received adjuvant without powder; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a elderly male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: patient received adjuvant without powder) and inappropriate dose of vaccine administered (Verbatim: patient received adjuvant without powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 15-OCT-2025 Healthcare professional wanted to know if patient could now receive a full dose of Arexvy. It was the reporter who reported it who administered to patient. No lot or expiration date was available during call with the reporter. The batch number was not provided upon follow- up with the reporter.